Application of pharmacokinetic modelling for 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure assessmentFootnote

^£Presented at the 16th International Workshop on Quantitative Structure–Activity Relationships in Environmental and Health Sciences (QSAR2014), 16–20 June 2014, Milan, Italy.

References

• M. Van den Berg, L. Birnbaum, A.T. Bosveld, B. Brunstrom, P. Cook, M. Feeley, J.P. Giesy, A. Hanberg, R. Hasegawa, S.W. Kennedy, T. Kubiak, J.C. Larsen, F.X. van Leeuwen, A.K. Liem, C. Nolt, R.E. Peterson, L. Poellinger, S. Safe, D. Schrenk, D. Tillitt, M. Tysklind, M. Younes, F. Waern, and T. Zacharewski, Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife, Environ. Health Perspect. 106 (1998), pp. 775–792.10.1289/ehp.98106775
   PubMed Web of Science ®Google Scholar
• M. van den Berg, R.E. Peterson, and D. Schrenk, Human risk assessment and TEFs, Food Addit. Contam. 17 (2000), pp. 347–358.10.1080/026520300283414
   PubMedGoogle Scholar
• M. Van den Berg, L.S. Birnbaum, M. Denison, M. De Vito, W. Farland, M. Feeley, H. Fiedler, H. Hakansson, A. Hanberg, L. Haws, M. Rose, S. Safe, D. Schrenk, C. Tohyama, A. Tritscher, J. Tuomisto, M. Tysklind, N. Walker, and R.E. Peterson, The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compounds, Toxicol. Sci. 93 (2006), pp. 223–241.
   Google Scholar
• L.L. Aylward and S.M. Hays, Temporal trends in human TCDD body burden: Decreases over three decades and implications for exposure levels, J. Expo. Anal. Environ. Epidemiol. 12 (2002), pp. 319–328.10.1038/sj.jea.7500233
   PubMedGoogle Scholar
• R.A. Budinsky, D. Schrenk, T. Simon, M. Van den Berg, J.F. Reichard, J.B. Silkworth, L.L. Aylward, A. Brix, T. Gasiewicz, N. Kaminski, G. Perdew, T.B. Starr, N.J. Walker, and J.C. Rowlands, Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study, Crit. Rev. Toxicol. 44 (2014), pp. 83–8119.10.3109/10408444.2013.835787
   PubMed Web of Science ®Google Scholar
• M.S. Denison, A.A. Soshilov, G. He, D.E. DeGroot, and B. Zhao, Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor, Toxicol. Sci. 124 (2011), pp. 1–22.10.1093/toxsci/kfr218
   PubMed Web of Science ®Google Scholar
• L.L. Aylward, R.C. Brunet, T.B. Starr, G. Carrier, E. Delzell, H. Cheng, and C. Beall, Exposure reconstruction for the TCDD-exposed NIOSH cohort using a concentration- and age-dependent model of elimination, Risk. Anal. 25 (2005), pp. 945–956.10.1111/risk.2005.25.issue-4
   PubMed Web of Science ®Google Scholar
• L.L. Aylward, R.C. Brunet, G. Carrier, S.M. Hays, C.A. Cushing, L.L. Needham, D.G. Patterson, P.M. Gerthoux, P. Brambilla, and P. Mocarelli, Concentration-dependent TCDD elimination kinetics in humans: Toxicokinetic modeling for moderately to highly exposed adults from Seveso, Italy, and Vienna, Austria, and impact on dose estimates for the NIOSH cohort, J. Expo. Anal. Environ. Epidemiol. 15 (2005), pp. 51–65.10.1038/sj.jea.7500370
   PubMedGoogle Scholar
• G. Carrier, R.C. Brunet, and J. Brodeur, Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs, Toxicol. Appl. Pharmacol. 131 (1995), pp. 267–276.10.1006/taap.1995.1069
   PubMed Web of Science ®Google Scholar
• G. Carrier, R.C. Brunet, and J. Brodeur, Modeling of the toxicokinetics of polychlorinated dibenzo-p-dioxins and dibenzofurans in mammalians, including humans. II. Kinetics of absorption and disposition of PCDDs/PCDFs, Toxicol. Appl. Pharmacol. 131 (1995), pp. 267–276.10.1006/taap.1995.1069
   PubMed Web of Science ®Google Scholar
• M. Lorber, A pharmacokinetic model for estimating exposure of Americans to dioxin-like compounds in the past, present, and future, Sci. Total Environ. 288 (2002), pp. 81–95.10.1016/S0048-9697(01)01119-6
   PubMed Web of Science ®Google Scholar
• W. Maruyama, K. Yoshida, T. Tanaka, and J. Nakanishi, Determination of tissue-blood partition coefficients for a physiological model for humans, and estimation of dioxin concentration in tissues, Chemosphere 46 (2002), pp. 975–985.10.1016/S0045-6535(01)00208-9
   PubMed Web of Science ®Google Scholar
• G.W. van der Molen, S.A. Kooijman, and W. Slob, A generic toxicokinetic model for persistent lipophilic compounds in humans: An application to TCDD, Fundam. Appl. Toxicol. 31 (1996), pp. 83–94.10.1006/faat.1996.0079
   PubMedGoogle Scholar
• M.O.G. Milbrath, Y. Wenger, C.-W. Chang, C. Emond, D. Garabrant, B.W. Gillespie, and O. Jolliet, Apparent half-lives of dioxins, furans, and polychlorinated biphenyls as a function of age, body fat, smoking status, and breast-feeding, Environ. Health Perspect. 117 (2009), pp. 417–425.10.1289/ehp.11781
   PubMed Web of Science ®Google Scholar
• M.M. Mumtaz, M. Ray, S.R. Crowell, D. Keys, J. Fisher, and P. Ruiz, Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs), J. Toxicol. Environ. Health A 75 (2012), pp. 6–24.10.1080/15287394.2012.625546
   PubMed Web of Science ®Google Scholar
• P. Ruiz, B.A. Fowler, J.D. Osterloh, J. Fisher, and M. Mumtaz, Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants—metals, SAR QSAR Environ. Res. 21 (2010), pp. 603–618.10.1080/1062936X.2010.528942
   PubMed Web of Science ®Google Scholar
• P. Ruiz, M. Mumtaz, J. Osterloh, J. Fisher, and B.A. Fowler, Interpreting NHANES biomonitoring data, cadmium, Toxicol. Lett. 198 (2010), pp. 44–48.10.1016/j.toxlet.2010.04.022
   PubMed Web of Science ®Google Scholar
• P. Ruiz, M. Ray, J. Fisher, and M. Mumtaz, Development of a Human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants, Int. J. Mol. Sci. 12 (2011), pp. 7469–7480.10.3390/ijms12117469
   PubMed Web of Science ®Google Scholar
• M.A. McDowell, C.D. Fryar, R. Hirsch, and C.L. Ogden, Anthropometric reference data for children and adults: U.S. population, 1999–2002, Adv. Data (2005), pp. 1–5.
   PubMedGoogle Scholar
• D.A. Revicki and R.G. Israel, Relationship between body mass indices and measures of body adiposity, Am. J. Public Health 76 (1986), pp. 992–994.10.2105/AJPH.76.8.992
   PubMed Web of Science ®Google Scholar
• P. Deurenberg, J.A. Weststrate, and J.C. Seidell, Body mass index as a measure of body fatness: Age- and sex-specific prediction formulas, Br. J. Nutr. 65 (1991), pp. 105–114.10.1079/BJN19910073
   PubMed Web of Science ®Google Scholar
• P.S. Price, R.B. Conolly, C.F. Chaisson, E.A. Gross, J.S. Young, E.T. Mathis, and D.R. Tedder, Modeling interindividual variation in physiological factors used in PBPK models of humans, Crit. Rev. Toxicol. 33 (2003), pp. 469–503.10.1080/10408440390242324
   PubMed Web of Science ®Google Scholar
• T. Noda, T. Todani, Y. Watanabe, and S. Yamamoto, Liver volume in children measured by computed tomography, Pediatr. Radiol. 27 (1997), pp. 250–252.10.1007/s002470050114
   PubMed Web of Science ®Google Scholar
• B.D. Kerger, H.-W. Leung, P.K. Scott, and D.J. Paustenbach, An adaptable internal dose model for risk assessment of dietary and soil dioxin exposures in young children, Toxicol. Sci. 100 (2007), pp. 224–237.10.1093/toxsci/kfm199
   PubMed Web of Science ®Google Scholar
• T. Simon, L.L. Aylward, C.R. Kirman, J.C. Rowlands, and R.A. Budinsky, Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics, Toxicol. Sci. 112 (2009), pp. 490–506.10.1093/toxsci/kfp232
   PubMed Web of Science ®Google Scholar
• O. Sorg, M. Zennegg, P. Schmid, R. Fedosyuk, R. Valikhnovskyi, O. Gaide, V. Kniazevych, and J.H. Saurat, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: Identification and measurement of TCDD metabolites, Lancet 374 (2009), pp. 1179–1185.10.1016/S0140-6736(09)60912-0
   PubMed Web of Science ®Google Scholar
• T. Iida, H. Hirakawa, T. Matsueda, J. Nagayama, and T. Nagata, Polychlorinated dibenzo-p-dioxins and related compounds: Correlations of levels in human tissues and in blood, Chemosphere 38 (1999), pp. 2767–2774.10.1016/S0045-6535(98)00478-0
   PubMed Web of Science ®Google Scholar
• T. Iida, H. Hirakawa, T. Matsueda, S. Takenaka, and J. Nagayama, Polychlorinated dibenzo-p-dioxins and related compounds: The blood levels of young Japanese women, Chemosphere 38 (1999), pp. 3497–3502.10.1016/S0045-6535(98)00579-7
   PubMed Web of Science ®Google Scholar
• K. Arisawa, H. Uemura, M. Hiyoshi, H. Satoh, Y. Sumiyoshi, K. Morinaga, K. Kodama, T.-I. Suzuki, M. Nagai, and T. Suzuki, Dietary intake of PCDDs/PCDFs and coplanar PCBs among the Japanese population estimated by duplicate portion analysis: A low proportion of adults exceed the tolerable daily intake, Environ. Res. 108 (2008), pp. 252–259.10.1016/j.envres.2008.06.011
   PubMed Web of Science ®Google Scholar
• K. Abraham, O. Papke, A. Gross, O. Kordonouri, S. Wiegand, U. Wahn, and H. Helge, Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants, Chemosphere 37 (1998), pp. 1731–1741.10.1016/S0045-6535(98)00238-0
   PubMed Web of Science ®Google Scholar
• L.L. Ferriby, J.S. Knutsen, M. Harris, K.M. Unice, P. Scott, P. Nony, L.C. Haws, and D. Paustenbach, Evaluation of PCDD/F and dioxin-like PCB serum concentration data from the 2001–2002 National Health and Nutrition Examination Survey of the United States population, J. Expo. Sci. Environ. Epidemiol. 17 (2007), pp. 358–371.10.1038/sj.jes.7500498
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC), National Biomonitoring Program. Available at: http://www.cdc.gov/biomonitoring/environmental_chemicals.html.
   Google Scholar
• D.G. Patterson, W.E. Turner, S.P. Caudill, and L.L. Needham, Total TEQ reference range (PCDDs, PCDFs, cPCBs, mono-PCBs) for the US population 2001–2002, Chemosphere 73 (2008), pp. 261–277.10.1016/j.chemosphere.2007.08.074
   PubMed Web of Science ®Google Scholar
• D.G. Patterson, L.-Y. Wong, W.E. Turner, S.P. Caudill, E.S. Dipietro, P.C. McClure, T.P. Cash, J.D. Osterloh, J.L. Pirkle, E.J. Sampson, and L.L. Needham, Levels in the U.S. population of those persistent organic pollutants (2003–2004) included in the Stockholm Convention or in other long range transboundary air pollution agreements, Environ. Sci. Technol. 43 (2009), pp. 1211–1218.10.1021/es801966w
   PubMed Web of Science ®Google Scholar
• J.S. LaKind, S.M. Hays, L.L. Aylward, and D.Q. Naiman, Perspective on serum dioxin levels in the United States: An evaluation of the NHANES data, J. Expo. Sci. Environ. Epidemiol. 19 (2009), pp. 435–441.10.1038/jes.2008.63
   PubMed Web of Science ®Google Scholar
• W. Maruyama, K. Yoshida, T. Tanaka, and J. Nakanishi, Simulation of dioxin accumulation in human tissues and analysis of reproductive risk, Chemosphere 53 (2003), pp. 301–313.10.1016/S0045-6535(03)00015-8
   PubMed Web of Science ®Google Scholar
• G.H. Lambert, L.L. Needham, W. Turner, T.J. Lai, D.G. Patterson, and Y.L. Guo, Induced CYP1A2 activity as a phenotypic biomarker in humans highly exposed to certain PCBs/PCDFs, Environ. Sci. Technol. 40 (2006), pp. 6176–6180.10.1021/es0608646
   PubMed Web of Science ®Google Scholar
• K. Abraham, A. Geusau, Y. Tosun, H. Helge, S. Bauer, and J. Brockmoller, Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Insights into the measurement of hepatic cytochrome P450 1A2 induction, Clin. Pharmacol. Ther. 72 (2002), pp. 163–174.10.1067/mcp.2002.126408
   PubMed Web of Science ®Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological profile for chlorinated dibenzo-p-dioxins, US Department of Health and Human Services, Public Health Service, Atlanta, GA, 1998.
   Google Scholar
• Agency for Toxic Substances and Disease Registry (ATSDR), Toxicological profile for chlorinated dibenzo-p-dioxins. Addenda, US Department of Health and Human Services, Public Health Service, Atlanta, GA, 2012.
   Google Scholar
• H.R. Pohl and B.F. Hibbs, Breast-feeding exposure of infants to environmental contaminants. A public health risk assessment viewpoint: Chlorinated dibenzodioxins and chlorinated dibenzofurans, Toxicol. Ind. Health 12 (1996), pp. 593–611.10.1177/074823379601200501
   PubMed Web of Science ®Google Scholar
• H.R. Pohl, P. McClure, and C.T.D. Rosa, Persistent chemicals found in breast milk and their possible interactions, Environ. Toxicol. Pharmacol. 18 (2004), pp. 259–266.10.1016/j.etap.2003.11.012
   PubMed Web of Science ®Google Scholar
• P.E. Kreuzer, G.A. Csanady, C. Baur, W. Kessler, O. Papke, H. Greim, and J.G. Filser, 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition, Arch. Toxicol. 71 (1997), pp. 383–400.10.1007/s002040050402
   PubMed Web of Science ®Google Scholar
• M. Lorber and L. Phillips, Infant exposure to dioxin-like compounds in breast milk, Environ. Health Perspect. 110 (2002), pp. 325–332.10.1289/ehp.021100325
   PubMed Web of Science ®Google Scholar
• P.J. Boogaard, S.M. Hays, and L.L. Aylward, Human biomonitoring as a pragmatic tool to support health risk management of chemicals: Examples under the EU REACH programme, Regul. Toxicol. Pharmacol. 59 (2011), pp. 125–132.10.1016/j.yrtph.2010.09.015
   PubMed Web of Science ®Google Scholar
• ESBIO, Expert team to support biomonitoring in Europe. Available at: http://www.eu-humanbiomonitoring.org/sub/esbio.htm.
   Google Scholar
• Consortium to Perform Human Biomonitoring on a European Scale (COPHES), Human biomonitoring for Europe: A harmonised approach. Available at: http://www.eu-hbm.info/cophes.
   Google Scholar
• Canadian Health Measures Survey (CHMS), Canadian Health Measures Survey. Available at: http://www.statcan.gc.ca/imdb-bmdi/5071-eng.htm.
   Google Scholar
• M. Schlummer, G.A. Moser, and M.S. McLachlan, Digestive tract absorption of PCDD/Fs, PCBs, and HCB in humans: Mass balances and mechanistic considerations, Toxicol. Appl. Pharmacol. 152 (1998), pp. 128–137.10.1006/taap.1998.8487
   PubMed Web of Science ®Google Scholar
• S. Rohde, G.A. Moser, O. Papke, and M.S. McLachlan, Clearance of PCDD/Fs via the gastrointestinal tract in occupationally exposed persons, Chemosphere 38 (1999), pp. 3397–3410.10.1016/S0045-6535(98)00551-7
   PubMed Web of Science ®Google Scholar
• Geusau, S. Schmaldienst, K. Derfler, O. Papke, and K. Abraham, Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Kinetics and trials to enhance elimination in two patients, Arch. Toxicol. 76 (2002), pp. 316–325.10.1007/s00204-002-0345-7
   PubMed Web of Science ®Google Scholar
• R. Ritter, M. Scheringer, M. MacLeod, U. Schenker, and K. Hungerbuhler, A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: Application to a postban situation, Environ. Health Perspect. 117 (2009), pp. 1280–1286.10.1289/ehp.0900648
   PubMed Web of Science ®Google Scholar
• R. Ritter, M. Scheringer, M. MacLeod, C. Moeckel, K.C. Jones, and K. Hungerbuhler, Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom, Environ. Health Perspect. 119 (2011), pp. 225–231.
   PubMed Web of Science ®Google Scholar
• National Research Council (NRC), Toxicity Testing in the 21st Century: A Vision and a Strategy, National Academies Press, Washington DC, 2007.
   Google Scholar
• R.S. Thomas, M.B. Black, L. Li, E. Healy, T.-M. Chu, W. Bao, M.E. Andersen, and R.D. Wolfinger, A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening, Toxicol. Sci. 128 (2012), pp. 398–417.10.1093/toxsci/kfs159
   PubMed Web of Science ®Google Scholar
• R. Judson, A. Richard, D. Dix, K. Houck, F. Elloumi, M. Martin, T. Cathey, T.R. Transue, R. Spencer, and M. Wolf, ACToR—Aggregated Computational Toxicology Resource, Toxicol. Appl. Pharmacol. 233 (2008), pp. 7–13.10.1016/j.taap.2007.12.037
   PubMed Web of Science ®Google Scholar
• National Center for Environmental Assessment (NCEA), US Environmental Protection Agency, EPA’s reanalysis of key issues related to dioxin toxicity and response to NAS comments, Volume 1, EPA/600/R-10/038F, US Environmental Protection Agency, Washington DC, 2012.
   Google Scholar
• D.J. Dix, K.A. Houck, M.T. Martin, A.M. Richard, R.W. Setzer, and R.J. Kavlock, The ToxCast program for prioritizing toxicity testing of environmental chemicals, Toxicol. Sci. 95 (2007), pp. 5–12.
   PubMed Web of Science ®Google Scholar
• C. Emond, J.E. Michalek, L.S. Birnbaum, and M.J. Devito, Comparison of the use of a physiologically based pharmacokinetic model and a classical pharmacokinetic model for dioxin exposure assessments, Environ. Health Perspect. 113 (2005), pp. 1666–1668.10.1289/ehp.8016
   PubMed Web of Science ®Google Scholar
• C. Emond, L.S. Birnbaum, and M.J. DeVito, Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD, Environ. Health Perspect. 114 (2006), pp. 1394–400.10.1289/ehp.8805
   PubMed Web of Science ®Google Scholar